ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

OMB Proposal Would Slash NIH Budget $500 Million, NCI’s Reduction Could Be As Much As $125 Million

January 3, 1986

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

Sandra Horning elected ASCO president-elect.

February 27, 2004

ASCO Survey Finds Docs’ Quality Time With Patients Down, Due To Paperwork.

June 22, 2001

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013